<DOC>
	<DOCNO>NCT02964546</DOCNO>
	<brief_summary>Atrial fibrillation elderly complex condition due high number frequently associate comorbidities kidney disease . Direct oral anticoagulant ( dabigatran , rivaroxaban apixaban ) indicate prevent thromboembolic event renal function closely monitored age group drug use . Dosing recommendation prevention stroke base renal clearance creatinine ( ClCr ) estimate use Cockcroft-Gault formula . It well know ClCr estimate predict steep decline advance age Glomerular Filtration Rate ( GFR ) estimate . This raise possibility substitution commonly report GFR estimate CrCl could result different plasmatic concentration oral direct anticoagulant . The aim study compare estimate ClCr GFR determine impact plasmatic concentration drug elderly patient non-valvular atrial fibrillation .</brief_summary>
	<brief_title>Glomerular Filtration Rate-Estimating Equations During Use Direct Oral Anticoagulants Elderly Patients</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients nonvalvular atrial fibrillation treat dabigatran , rivaroxaban apixaban patient affiliate national social health system patient agree ethical concern study Patients consultation hospitalization make impossible veinous punction steady state residual concentration time Patients guardianship trusteeship</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>direct oral anticoagulant</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>renal function</keyword>
	<keyword>ckd-epi</keyword>
	<keyword>plasmatic concentration</keyword>
</DOC>